Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular
- PMID: 29264927
- PMCID: PMC5874330
- DOI: 10.1177/1091581817741840
Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular
Abstract
As the need for nasal, ocular, spinal, and articular therapeutic compounds increases, toxicology assessments of drugs administered via these routes play an important role in human safety. This symposium outlined the local and systemic evaluation to support safety during the development of these drugs in nonclinical models with some case studies. Discussions included selection of appropriate species for the intended route; conducting nonclinical studies that closely mimic the intended use with adequate duration; functional assessment, if deemed necessary; evaluation of local tissues with special histological staining procedure; and evaluations of safety margins based on local and systemic toxicity.
Keywords: analgesics; antispasticity; epidural; granuloma; intra-articular; intracameral; intranasal; intrathecal; intravitreal; local toxicity; safety evaluation; safety margins; spinal cord; toxicity.
Conflict of interest statement
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures







Similar articles
-
Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.Int J Toxicol. 2007 Sep-Oct;26(5):411-21. doi: 10.1080/10915810701582970. Int J Toxicol. 2007. PMID: 17963128
-
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.Eur J Pharm Biopharm. 2014 Sep;88(1):8-27. doi: 10.1016/j.ejpb.2014.03.004. Epub 2014 Mar 28. Eur J Pharm Biopharm. 2014. PMID: 24681294 Review.
-
General considerations in ocular toxicity risk assessment from the toxicologists' viewpoints.J Toxicol Sci. 2015 Jun;40(3):295-307. doi: 10.2131/jts.40.295. J Toxicol Sci. 2015. PMID: 25972191 Review.
-
Best practices for managing quality and safety of foreign particles in orally inhaled and nasal drug products, and an evaluation of clinical relevance.Pharm Res. 2007 Mar;24(3):471-9. doi: 10.1007/s11095-006-9172-5. Pharm Res. 2007. PMID: 17252189 No abstract available.
-
Nasal and buccal drug delivery: management forum conference.Ther Deliv. 2012 Jul;3(7):819-22. doi: 10.4155/tde.12.60. Ther Deliv. 2012. PMID: 22900464
Cited by
-
Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures.Nanoscale Adv. 2020 Jul 22;2(9):3815-3820. doi: 10.1039/d0na00521e. eCollection 2020 Sep 16. Nanoscale Adv. 2020. PMID: 36132776 Free PMC article.
-
Progress and Challenges of Topical Delivery Technologies Meditated Drug Therapy for Osteoarthritis.Int J Nanomedicine. 2024 Aug 14;19:8337-8352. doi: 10.2147/IJN.S466437. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39161359 Free PMC article. Review.
-
Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice.ACS Appl Mater Interfaces. 2022 Feb 9;14(5):6331-6342. doi: 10.1021/acsami.1c19192. Epub 2022 Jan 27. ACS Appl Mater Interfaces. 2022. PMID: 35084819 Free PMC article.
-
Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).Front Immunol. 2022 Dec 8;13:1063679. doi: 10.3389/fimmu.2022.1063679. eCollection 2022. Front Immunol. 2022. PMID: 36569867 Free PMC article.
-
Frontiers in Pain Research: A Scope of Its Focus and Content.Front Pain Res (Lausanne). 2020 Oct 29;1:601528. doi: 10.3389/fpain.2020.601528. eCollection 2020. Front Pain Res (Lausanne). 2020. PMID: 35295691 Free PMC article. No abstract available.
References
-
- Illum L. Nasal clearance in health and disease. J Aerosol Med. 2006 Spring;19(1):92–9. - PubMed
-
- Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ, Le Guen M, Fischler M, Devillier P. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther. 2012 Jun;134(3):366–79. Reed (1993) - PubMed
-
- Fortuna A, Alves G, Serralheiro A, Sousa J, Falcão A. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules. Eur J Pharm Biopharm. 2014 Sep;88(1):8–27. - PubMed
-
- Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J. Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv. 2014 Mar;21(2):75–86. - PubMed
-
- Pires A, Fortuna A, Alves G, Falcão A. Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci. 2009;12(3):288–311. Review. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials